Research Findings Indicate Ivacaftor May Decrease Common Infections in CF Patients

Patients with cystic fibrosis (CF) who take the drug, Ivacaftor, appear to have fewer respiratory infections over time than those not taking the drug, according to new research findings published online in the Annuals of the American Thoracic Society. The hereditary disorder, Cystic fibrosis, is caused by mutations in the cystic fibrosis transmembrane conductance regulator …

Research Findings Indicate Ivacaftor May Decrease Common Infections in CF Patients Read More »